Infliximab Efficacy in Relation to Therapeutic Drug Monitoring and Serum TNFα Levels in Pediatric HSCT

Clinical trial NCT05825833 · COMPLETED

Trial details

NCT number: NCT05825833
Sponsor: IRCCS Burlo Garofolo
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Graft-versus-host Disease

Start date: 2022-03-10
Primary completion: 2022-12-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.